Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant expression system for human anti-inflammatory phospholipase inhibitor protein

Recombinant expression system for human anti-inflammatory phospholipase inhibitor protein

US Patent 5342764 · Granted Aug 30, 1994

Estimated economic value: $4,043,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulation2022
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives2015
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives2014
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the t2013
Methods for treating diarrhea-associated irritable bowel syndrome2012
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives2009
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives2008
Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreven1999
Antibodies for human phospholipase inhibitory protein (hPIP)1997
Antibodies for human phospholipase inhibitory protein (hPIP)1997
Antibodies that specifically bind to and inhibit human synovial phospholipase A.1996
Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreven1996